{"id":"doi:10.1136/jitc-2021-002435","kind":"article","title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","authors":["Julie Renee Brahmer","Hamzah Abu‐Sbeih","Paolo A. Ascierto","Jill Weiskopf Brufsky","Laura C. Cappelli","Frank B. Cortazar","David E. Gerber","Lamya Hamad","Eric Hansen","Douglas Buckner Johnson","Mario E. Lacouture","Gregory A. Masters","Jarushka Naidoo","Michele Nanni","Miguel‐Angel Perales","Igor J. Puzanov","Bianca Santomasso","Satish Shanbhag","Rajeev Sharma","Dimitra Skondra","Jeffrey Alan Sosman","Michelle Turner","Marc S. Ernstoff"],"author_count":23,"year":2021,"published":"2021-06-01","venue":"Journal for ImmunoTherapy of Cancer","cited_by":916,"doi":"10.1136/jitc-2021-002435","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1136/jitc-2021-002435","archive_url":"https://space-kitty.com/papers/doi:10.1136/jitc-2021-002435","updated":null,"pmid":"34172516","pmcid":null,"openalex_id":"W3174077356","pdf_url":"https://jitc.bmj.com/content/jitc/9/6/e002435.full.pdf","abstract":null,"abstract_license":null,"license":"other-oa","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}